BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32719966)

  • 1. The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer's Disease.
    Gao P; Ye L; Cheng H; Li H
    Cell Mol Neurobiol; 2021 Oct; 41(7):1431-1440. PubMed ID: 32719966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology.
    Kaur I; Behl T; Sundararajan G; Panneerselvam P; Vijayakumar AR; Senthilkumar GP; Venkatachalam T; Jaglan D; Yadav S; Anwer K; Fuloria NK; Sehgal A; Gulati M; Chigurupati S
    Neurotox Res; 2023 Dec; 41(6):698-707. PubMed ID: 37847429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.
    Zhou Y; Hayashi I; Wong J; Tugusheva K; Renger JJ; Zerbinatti C
    PLoS One; 2014; 9(7):e103187. PubMed ID: 25051234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology.
    Holler CJ; Davis PR; Beckett TL; Platt TL; Webb RL; Head E; Murphy MP
    J Alzheimers Dis; 2014; 42(4):1221-7. PubMed ID: 25024306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.
    Wang HF; Wan Y; Hao XK; Cao L; Zhu XC; Jiang T; Tan MS; Tan L; Zhang DQ; Tan L; Yu JT;
    J Alzheimers Dis; 2016 Mar; 52(1):179-90. PubMed ID: 27003210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging.
    Glennon EB; Whitehouse IJ; Miners JS; Kehoe PG; Love S; Kellett KA; Hooper NM
    PLoS One; 2013; 8(10):e78806. PubMed ID: 24205320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.
    Chapuis J; Hansmannel F; Gistelinck M; Mounier A; Van Cauwenberghe C; Kolen KV; Geller F; Sottejeau Y; Harold D; Dourlen P; Grenier-Boley B; Kamatani Y; Delepine B; Demiautte F; Zelenika D; Zommer N; Hamdane M; Bellenguez C; Dartigues JF; Hauw JJ; Letronne F; Ayral AM; Sleegers K; Schellens A; Broeck LV; Engelborghs S; De Deyn PP; Vandenberghe R; O'Donovan M; Owen M; Epelbaum J; Mercken M; Karran E; Bantscheff M; Drewes G; Joberty G; Campion D; Octave JN; Berr C; Lathrop M; Callaerts P; Mann D; Williams J; Buée L; Dewachter I; Van Broeckhoven C; Amouyel P; Moechars D; Dermaut B; Lambert JC;
    Mol Psychiatry; 2013 Nov; 18(11):1225-34. PubMed ID: 23399914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models.
    De Rossi P; Andrew RJ; Musial TF; Buggia-Prevot V; Xu G; Ponnusamy M; Ly H; Krause SV; Rice RC; de l'Estoile V; Valin T; Salem S; Despa F; Borchelt DR; Bindokas VP; Nicholson DA; Thinakaran G
    Brain Pathol; 2019 Jul; 29(4):485-501. PubMed ID: 30506549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts.
    De Rossi P; Buggia-Prévot V; Clayton BL; Vasquez JB; van Sanford C; Andrew RJ; Lesnick R; Botté A; Deyts C; Salem S; Rao E; Rice RC; Parent A; Kar S; Popko B; Pytel P; Estus S; Thinakaran G
    Mol Neurodegener; 2016 Aug; 11(1):59. PubMed ID: 27488240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease risk gene
    Voskobiynyk Y; Roth JR; Cochran JN; Rush T; Carullo NV; Mesina JS; Waqas M; Vollmer RM; Day JJ; McMahon LL; Roberson ED
    Elife; 2020 Jul; 9():. PubMed ID: 32657270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
    Ponnusamy M; Wang S; Yuksel M; Hansen MT; Blazier DM; McMillan JD; Zhang X; Dammer EB; Collier L; Thinakaran G
    Brain; 2023 Apr; 146(4):1561-1579. PubMed ID: 36059072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.
    Franzmeier N; Rubinski A; Neitzel J; Ewers M;
    Nat Commun; 2019 Apr; 10(1):1766. PubMed ID: 30992433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease.
    Thomas S; Hoxha K; Tran A; Prendergast GC
    J Cell Biochem; 2019 Oct; 120(10):18320-18331. PubMed ID: 31211444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr
    Sartori M; Mendes T; Desai S; Lasorsa A; Herledan A; Malmanche N; Mäkinen P; Marttinen M; Malki I; Chapuis J; Flaig A; Vreulx AC; Ciancia M; Amouyel P; Leroux F; Déprez B; Cantrelle FX; Maréchal D; Pradier L; Hiltunen M; Landrieu I; Kilinc D; Herault Y; Laporte J; Lambert JC
    Acta Neuropathol; 2019 Oct; 138(4):631-652. PubMed ID: 31065832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIN1 favors the spreading of Tau via extracellular vesicles.
    Crotti A; Sait HR; McAvoy KM; Estrada K; Ergun A; Szak S; Marsh G; Jandreski L; Peterson M; Reynolds TL; Dalkilic-Liddle I; Cameron A; Cahir-McFarland E; Ransohoff RM
    Sci Rep; 2019 Jul; 9(1):9477. PubMed ID: 31263146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease BIN1 coding variants increase intracellular Aβ levels by interfering with BACE1 recycling.
    Perdigão C; Barata MA; Burrinha T; Guimas Almeida C
    J Biol Chem; 2021 Sep; 297(3):101056. PubMed ID: 34375641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly.
    Greenbaum L; Ravona-Springer R; Lubitz I; Schmeidler J; Cooper I; Sano M; Silverman JM; Heymann A; Beeri MS
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):787-95. PubMed ID: 26947052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology.
    Adams SL; Tilton K; Kozubek JA; Seshadri S; Delalle I
    J Neuropathol Exp Neurol; 2016 Aug; 75(8):779-790. PubMed ID: 27346750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.